Cardiac imaging AI company Heartflow raised $364 million from an upsized public stock offering, far exceeding expectations.
Key Details
- 1Heartflow is an imaging AI vendor specializing in noninvasive CT-based cardiac tests.
- 2The company raised $364 million from its IPO, up from the original $100 million target.
- 3Shares were sold at $19 each, with over 19 million shares issued.
- 4Heartflow uses CT data to generate personalized 3D models of coronary arteries.
- 5The company reported $126 million in revenue last year, growing 44% year-over-year.
- 6Estimated market opportunity for Heartflow's products exceeds $5 billion.
Why It Matters
This large capital raise highlights both investor confidence and strong demand for AI-powered cardiac imaging solutions. The funding will help Heartflow expand its reach among radiologists and further develop its imaging AI technology.
Source
Radiology Business
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•Radiology Business
Private Equity Backs AIRS Medical to Expand MRI AI Globally
TA Associates is investing in AIRS Medical to accelerate its global expansion of AI-powered MRI efficiency solutions.
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.